BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32159784)

  • 21. Follow-up genotoxicity assessment of Ames-positive/equivocal chemicals using the improved thymidine kinase gene mutation assay in DNA repair-deficient human TK6 cells.
    Sassa A; Fukuda T; Ukai A; Nakamura M; Sato R; Fujiwara S; Hirota K; Takeda S; Sugiyama KI; Honma M; Yasui M
    Mutagenesis; 2021 Oct; 36(5):331-338. PubMed ID: 34216473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver-on-chip model and application in predictive genotoxicity and mutagenicity of drugs.
    Kopp B; Khawam A; Di Perna K; Lenart D; Vinette M; Silva R; Zanoni TB; Rore C; Guenigault G; Richardson E; Kostrzewski T; Boswell A; Van P; Valentine Iii C; Salk J; Hamel A
    Mutat Res Genet Toxicol Environ Mutagen; 2024; 896():503762. PubMed ID: 38821675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.
    Xuan J; Chen S; Ning B; Tolleson WH; Guo L
    Chem Biol Interact; 2016 Aug; 255():63-73. PubMed ID: 26477383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of hepatic cytochrome P450s in the cytotoxicity of dronedarone.
    Chen S; Wu Q; Ning B; Bryant M; Guo L
    Arch Toxicol; 2018 Jun; 92(6):1969-1981. PubMed ID: 29616291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of cytochrome P450 isoforms involved in 1-hydroxylation of pyrene.
    Kim YD; Todoroki H; Oyama T; Isse T; Matsumoto A; Yamaguchi T; Kim H; Uchiyama I; Kawamoto T
    Environ Res; 2004 Mar; 94(3):262-6. PubMed ID: 15016593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens.
    Penman BW; Chen L; Gelboin HV; Gonzalez FJ; Crespi CL
    Carcinogenesis; 1994 Sep; 15(9):1931-7. PubMed ID: 7923587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity.
    Chen S; Wu Q; Li X; Li D; Mei N; Ning B; Puig M; Ren Z; Tolleson WH; Guo L
    J Environ Sci Health C Toxicol Carcinog; 2021; 39(1):68-86. PubMed ID: 33576714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
    Westerink WM; Schoonen WG
    Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of the use of primary Chinese hamster liver cultures and genetically engineered immortal V79 Chinese hamster cell lines expressing rat liver CYP1A1, 1A2 and 2B1 cDNAs in micronucleus assays.
    Ellard S; Parry JM
    Toxicology; 1993 Oct; 82(1-3):131-49. PubMed ID: 8236272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
    Fujita K; Kamataki T
    Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1.
    Yamazaki H; Hatanaka N; Kizu R; Hayakawa K; Shimada N; Guengerich FP; Nakajima M; Yokoi T
    Mutat Res; 2000 Dec; 472(1-2):129-38. PubMed ID: 11113705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of P53 in HepG2 cells as surrogate to detect mutagens and promutagens in vitro.
    Boehme K; Dietz Y; Hewitt P; Mueller SO
    Toxicol Lett; 2010 Oct; 198(2):272-81. PubMed ID: 20655369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol.
    Shou M; Korzekwa KR; Crespi CL; Gonzalez FJ; Gelboin HV
    Mol Carcinog; 1994 Jul; 10(3):159-68. PubMed ID: 8043197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line.
    Hukkanen J; Lassila A; Päivärinta K; Valanne S; Sarpo S; Hakkola J; Pelkonen O; Raunio H
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):360-6. PubMed ID: 10696073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studies.
    Probert PM; Chung GW; Cockell SJ; Agius L; Mosesso P; White SA; Oakley F; Brown CD; Wright MC
    Toxicol Sci; 2014 Feb; 137(2):350-70. PubMed ID: 24235770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triphenyl phosphate induces clastogenic effects potently in mammalian cells, human CYP1A2 and 2E1 being major activating enzymes.
    Xie J; Tu H; Chen Y; Chen Z; Yang Z; Liu Y
    Chem Biol Interact; 2023 Jan; 369():110259. PubMed ID: 36372259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amplified and distinctive genotoxicity of titanium dioxide nanoparticles in transformed yeast reporters with human cytochrome P450 (CYP) genes.
    Jiang T; Hou L; Rahman SM; Gong Z; Bai X; Vulpe C; Fasullo M; Gu AZ
    J Hazard Mater; 2024 Aug; 474():134850. PubMed ID: 38850947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase.
    Shimada T; Gillam EM; Oda Y; Tsumura F; Sutter TR; Guengerich FP; Inoue K
    Chem Res Toxicol; 1999 Jul; 12(7):623-9. PubMed ID: 10409402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
    Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
    Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of short-term mutagenicity test systems in vitro: metabolic activation of indirectly acting mutagens by three immortal rat hepatocyte lines.
    Kulka U; Paul D; Bauchinger M
    Mutagenesis; 1993 May; 8(3):193-7. PubMed ID: 8332081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.